All studies and patients
|
MRI vs pathology
|
8
|
243
|
0.0 (−0.1, 0.2)
|
0 %
|
+/−3.8
|
Studies of MRI vs US
|
MRI vs pathology
|
5
|
123
|
0.1 (−0.2, 0.3)
|
0 %
|
+/− 2.8
|
US vs pathologya
|
5
|
123
|
−0.3 (−0.6, 0.1)
|
69 %
|
+/− 2.6
|
MRI and US (mean) vs pathology
|
5
|
123
|
−0.1 (−0.3, 0.1)
|
16 %
|
+/− 2.3
|
MRI vs USa
|
5
|
123
|
0.3 (−0.1, 0.7)
|
81 %
|
NA
|
MRI vs pathology (patients without US)b
|
3
|
14
|
−1.5 (−3.1, 0.1)
|
NA
|
+/− 6.0
|
Studies of MRI vs mammography
|
MRI vs pathology
|
4
|
78
|
0.1 (−0.1, 0.3)
|
0 %
|
+/− 4.1
|
Mammography vs pathology
|
4
|
78
|
0.0 (−0.3, 0.4)
|
39 %
|
+/− 5.0
|
MRI and mammography (mean) vs pathology
|
4
|
78
|
0.1 (−0.1, 0.4)
|
21 %
|
+/− 4.2
|
MRI vs mammography
|
4
|
78
|
0.1 (−0.2, 0.4)
|
0 %
|
NA
|
MRI vs pathology (patients without mammography)b
|
3
|
25
|
0.0 (−0.7, 0.7)
|
NA
|
+/− 3.5
|
Studies of MRI vs clinical examination
|
MRI vs pathology
|
3
|
107
|
0.0 (−0.2, 0.3)
|
0 %
|
+/− 4.2
|
Clinical examination vs pathologya
|
3
|
107
|
−0.8 (−1.5, −0.1)*
|
57 %
|
+/− 5.1
|
MRI and clinical examination (mean) vs pathology
|
3
|
107
|
−0.2 (−0.5, 0.1)
|
9 %
|
+/− 4.1
|
MRI vs clinical examinationa
|
3
|
107
|
0.9 (0.2, 1.5)*
|
56 %
|
NA
|
MRI vs pathology (patients without clinical examination)b
|
2
|
3
|
NA
c
|
NA
c
|
NA
c
|